Respiratory system meds - exam 3 Flashcards

1
Q

Methylxanthines Prototype

A

theophylline (Theolair)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

methylxanthines EPA

A

relaxes the bronchial smooth muscle, promoting bronchodilation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

methylxanthines therapeutic use

A

second line treatment for chronic lung disorders that cause bronchoconstriction (COPD) EBP no longer recommends to use to treat COPD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

methylxanthines administration

A

PO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

methylxanthines ADRs

A

tachycardia, agitation and seizures. Toxicity - ventricular dysrhythmias and convulsions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

methylxanthines contraindications and interactions

A

heart disease, liver dysfunction, and use with caution with seizure disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

methylxanthines RN intervention and client education

A

Need to monitor serum blood levels - narrow therapeutic range

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

inhaled glucocorticoids prototype

A

beclomethasone (QVAR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

inhaled glucocorticoids EPA

A

suppress the release of inflammatory mediators and decrease the recruitment of airway eosinophils. Increases the number and sensitivity of beta 2 adrenergic bronchodilators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

inhaled glucocorticoids therapeutic use

A

prophylactic management of asthma with inhaled steroids. Acute asthma flare-ups, systemic corticosteroids used

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

inhaled glucocorticoids administration

A

inhaled orally or nasally

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

inhaled glucocorticoids ADRs

A

pharyngitis, cough, dry mouth, and candidiasis (thrush)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

inhaled glucocorticoids contraindications and interactions

A

recent live virus immunization and oral candidiasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

inhaled glucocorticoids RN intervention and client education

A

Rinse mouth and throat with water after using inhaler
Use with a spacer
Educate client on how to administer inhaler

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

glucocorticoids prototype and other drug names

A

prednisone
Other: methylprednisone -IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

glucocorticoids EPA

A

multiple mechanisms of action and each one varies depending on the cell tissue. All affect the inflammatory process to reduce inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Glucocorticoids therapeutic use

A

decreases inflammatory symptoms and alters the immune response produced by nonendocrine disorders. Used to treat:
Asthma
COPD
Arthritis
Rhinitis
Cancer
Inflammatory bowel disease
Spinal cord injury
Prevention of acute adrenocortical insufficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

glucocorticoids administration

A

PO, IM, IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

glucocorticoids ADRs

A

if take 5 mg of glucocorticoids daily could result in the following AE:
CNS stimulant (jittery inside) - Insomnia
Adrenocortical insufficiency - Fainting, Weakness, Hypotension
Adrenocortical excess
Cardiovascular symptoms - Heart failure, Shock, Cardiac dysrhythmias
Increase appetite (weight gain)
Hyperglycemia… need to monitor patient with diabetes very carefully
Immunosuppressive - delayed wound healing more susceptible to infection
Bone disease
Very fragile skin… paper thin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

glucocorticoids Contraindications and interactions

A

immunosuppression, live vaccines, systemic fungal infections, antibiotic resistant infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

glucocorticoids RN intervention and client education

A

Treats symptoms, does not cure underlying disease
Take as directed, DO NOT stop taking abruptly
Tapered off
Take with food
Educate on numerous ADRs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

anti-inflammatory/leukotriene modifiers prototype

A

montelukast (Singulair)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

leukotriene modifiers EPA

A

prevents leukotrines from binding to its receptors therefore reducing bonchoconstriction, inflammation, and mucus production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

leukotriene modifiers therapeutic use

A

used in patient with asthma that do not respond to other treatments. Used as a long-acting antiasthmatic med. Only tablet approved for exercise-induced asthma. Can also treat allergies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
leukotriene modifiers administration
PO
26
leukotriene modifiers ADRs
behavioral changes BLACK BOX WARNING: neuropsychiatric events have been reported in pts that take this drug (aggressive behavior, hallucinations, insomnia, and suicidal ideation)
27
leukotriene modifiers contraindications and interactions
liver disease
28
leukotriene modifiers RN interventions and client education
Not used to manage acute asthma attack Take 2 hours before exercise to prevent exercise-induced asthma Take in evening daily to treat allergies
29
First generation/sedating antihistamines prototype
diphenhydramine (Benadryl)
30
first gen antihistamine therapeutic use
treat allergic reactions, anaphylaxis, motion sickness, and insomnia
31
first gen antihistamines EPA
structurally like histamine and occupy the same receptor sites preventing histamine acting on target tissues and thus preventing histamine response. Binds to central H1 receptors
32
first gen antihistamines administration
PO (tablet and liquid), topical ointment, IV and IM
33
first gen antihistamines ADRs
CNS depression = drowsiness and sedation, paradoxical effect causing CNS stimulation and anticholinergic effects
34
first gen antihistamines contraindications and interactions
Newborns and children <2 years Breastfeeding women Do not take with ETOH or other CNS depressants
35
first gen antihistamines RN intervention and client education
Do not take with ETOH or other CNS depressants Use with caution in older adults Assess LOC Advise against driving and operating machinery requiring mental alertness Can cause: Dry mouth, Urinary retention, Constipation, Blurred vision
36
second generation/nonsedating antihistamines prototype and other drug names
cetirizine (Zyrtec) Others: loratadine (Claritin) and fexofenadine (Allegra)
37
second gen antihistamines therapeutic use
treats seasonal allergies, and urticaria
38
second gen antihistamines EPA
binds to histamine receptors to prevent histamine response, but binds to peripheral, not central H1 receptors. Therefore, does not cause drowsiness like the first-generation agents
39
second gen antihistamines administration
PO, nasal
40
second gen antihistamines ADRs
drowsiness and fatigue (higher doses and anticholinergic effects)
41
second gen antihistamines contraindications and interaction
Breastfeeding women Impaired kidney or liver function
42
second gen antihistamines RN intervention and client education
Take once a day Take with water
43
sympathomimetics (nasal decongestants) prototype and other drug names
phenylephrine (neo-synephrine) Other: pseudoephedrine (Sudafed)
44
sympathomimetics therapeutic use
relieves pressure, swelling and congestion of the nasal mucosa
45
sympathomimetics EPA
alpha 1 adrenergic agonist, causes vasoconsrtiction of the blood vessels… causing the nasal turbinates in the nares to shrink, in turn opening nasal passages and relieving nasal congestion
46
sympathomimetics administration
PO (regular and XR tablets), topical and nasal sprays
47
sympathomimetics ADRs
CNS excitation = tachycardia, insomnia, dizziness, palpitations, urinary retention
48
sympathomimetics contraindications and interations
Uncontrolled heart disease Dysrhythmias HTN Narrow angle glaucoma Older adults Caffeine may increase effects
49
sympathomimetics RN intervention and client education
Do not use for more than 3 to 5 days Assess for cardiac symptoms Educate about rebound effect Rebound congestion Multiple drug interactions
50
antitussives - nonnarcotic prototype and other drug names
dextromethorphan (Delsym) Other drugs: benzonatate (Tessalon)
51
antitussives - nonnarcotic therapeutic use
to suppress nonproductive cough
52
antitussives - nonnarcotic EPA
depresses the cough reflex in the brain
53
antitussives - nonnarcotic administration
PO liquid, lozenge, syrup
54
antitussives - nonnarcotic ADRs
CNS depression - drowsiness and sedation
55
antitussives - nonnarcotic contraindications and interactions
MAOIs SSRIs ETOH use
56
antitussives RN intervention and client education
Medication interactions Avoid alcohol
57
antitussives - narcotic prototype
codeine
58
antitussives - narcotic therapeutic use
relief of cough
59
antitussives - narcotic EPA
depresses the cough reflex in the brain
60
antitussives - narcotic administration
PO, usually combined with acetaminophen in liquid form (tylenol #3)
61
antitussives - narcotic ADRs
nausea, vomiting, respiratory sedation, constipation and dizziness
62
antitussives - narcotic contraindications and interactions
Any respiratory impairments Head injuries Seizure disorders ETOH
63
antitussives - narcotic RN intervention and client education
Assess GI and respiratory status Avoid in patient with asthma or head injury
64
expectorants prototype
guaifenesin (Mucinex)
65
expectorants therapeutic use
loosens mucus from respiratory tract in a productive cough
66
expectorants EPA
reduces viscosity of secretions
67
expectorants administration
PO
68
expectorants ADRs
dizziness, drowsinessm HA, and skin rash
69
expectorants contraindications and interactions
Inability to expectorate
70
expectorants RN intervention and client education
Give med with food and water Hydration Swallow tablets whole Change positions carefully
71
mucolytics prototype
acetylcystine (Acetadote)
72
mucolytics therapeutic use
to liquify mucus in the respiratory tract
73
mucolytics EPA
attacks protein bonds in the mucus, reducing viscosity
74
mucolytics administration
Nebulizer, PO, and IV
75
mucolytics ADRs
bronchospsm, GI distress (due to rotten egg smell and ingestion of secretions)
76
mucolytics contraindications and interactions
Inability to expel secretions asthma
77
mucolytics RN intervention and client education
Assess respiratory status Difficulty breathing? Bronchospasm?Inability to expel secretions Hydration Report difficulty breathing or worsening cough